Evidence map›Paper›PMID 33708324›Full record

ArticleThe Pan African medical journal2020

Antimicrobial resistance pattern, genetic distribution of ESBL genes, biofilm-forming potential, and virulence potential of

Mohammad Shahbazzadeh, Elham Moazamian, Alireza Rafati, Masoud Fardin

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mohammad ShahbazzadehDepartment of Microbiology, Shiraz Branch, Islamic Azad University, Shiraz, Iran.
Elham MoazamianDepartment of Microbiology, Shiraz Branch, Islamic Azad University, Shiraz, Iran.
Alireza RafatiDepartment of Microbiology, Shiraz Branch, Islamic Azad University, Shiraz, Iran.
Masoud FardinDepartment of Microbiology, Ardabil Branch, Islamic Azad University, Ardabil, Iran.
Islamic Azad University of Shiraz · IRIslamic Azad University Ardabil · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionaccording to the studies performed, researchers considered Pseudomonas aeruginosa (P. aeruginosa) as the major cause of infectious diseases like burn and wound infection that makes it one of the most threatening opportunistic pathogens. The present research aimed at investigating antimicrobial resistance, biofilm-forming abilities, and frequency of the genes contributed to bla

methodswe evaluated the resistance of 156 P. aeruginosa isolates to fifteen antimicrobial agents and generation of the ESBL and MBL enzymes phenotypically based on the CLSI instructions. Moreover, the biofilm forming potential has been assayed in a microtitre plate. In addition, PCR has been used to examine the frequency of virulence-and biofilm-related genes. Furthermore, the PCR of bla

resultsaccording to the results, 72.2% of P. aeruginosa isolates have been MDR and 35.6% and 55.5% have been positive for producing MBL and ESBL, respectively. Moreover, 67.8% have been positive for forming biofilms. It has been found that 15.3% isolates are ESBL-positive; from among them 60% belong to the females and 40% belong to the males. In addition, one and two isolates respectively harbored the bla

conclusionthe present research outputs indicated the higher frequency of the multi drug resistance and higher percent of the virulence-related genes in the clinical P. aeruginosa isolates in Iran.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesBiofilmsBurnsDrug Resistance, Multiple, BacterialFemaleHospitalsHumansIranMalePolymerase Chain ReactionPseudomonas aeruginosaPseudomonas InfectionsVirulenceWound InfectionAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase blaPER-1, Pseudomonas aeruginosabeta-lactamase PSE-1beta-Lactamasesbeta-lactamase VEB-1, Pseudomonas aeruginosaantibiotic resistancebiofilmESBLsPseudomonas aeruginosavirulence

Identifiers

PMID33708324
PMCPMC7908313
OpenAlexW3046444368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.